CVS Group plc
CVS Group plc (CVSGF) Stock Competitors & Peer Comparison
See (CVSGF) competitors and their performances in Stock Market.
Peer Comparison Table: Personal Products & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CVSGF | $16.50 | +0.00% | 1.2B | 53.23 | $0.31 | +0.68% |
| BYDGF | $161.09 | +2.95% | 3.5B | 423.92 | $0.38 | +0.28% |
| PRRWF | $19.18 | -0.26% | 655.4M | -91.33 | -$0.21 | N/A |
| CRLKP | $22.50 | +0.00% | 498.7M | N/A | N/A | N/A |
| EDEMY | $40.00 | +0.00% | 421.5M | 5.12 | $7.81 | N/A |
| MIBE | $2.75 | +0.00% | 80.3M | N/A | N/A | N/A |
| WOSSF | $0.11 | +0.00% | 74.9M | 5.50 | $0.02 | +7.00% |
| MNNGF | $0.08 | +0.00% | 58M | -7.50 | -$0.01 | N/A |
| MNLXF | $0.24 | +0.00% | 40.2M | -4.00 | -$0.06 | N/A |
| KVIL | $0.00 | +0.00% | 30.5M | N/A | N/A | N/A |
Stock Comparison
CVSGF vs BYDGF Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, BYDGF has a market cap of 3.5B. Regarding current trading prices, CVSGF is priced at $16.50, while BYDGF trades at $161.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas BYDGF's P/E ratio is 423.92. In terms of profitability, CVSGF's ROE is +0.08%, compared to BYDGF's ROE of +0.02%. Regarding short-term risk, CVSGF is less volatile compared to BYDGF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check BYDGF's competition here
CVSGF vs PRRWF Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PRRWF has a market cap of 655.4M. Regarding current trading prices, CVSGF is priced at $16.50, while PRRWF trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas PRRWF's P/E ratio is -91.33. In terms of profitability, CVSGF's ROE is +0.08%, compared to PRRWF's ROE of -0.01%. Regarding short-term risk, CVSGF is less volatile compared to PRRWF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check PRRWF's competition here
CVSGF vs CRLKP Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CRLKP has a market cap of 498.7M. Regarding current trading prices, CVSGF is priced at $16.50, while CRLKP trades at $22.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas CRLKP's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to CRLKP's ROE of +0.43%. Regarding short-term risk, CVSGF and CRLKP have similar daily volatility (0.00).Check CRLKP's competition here
CVSGF vs EDEMY Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, EDEMY has a market cap of 421.5M. Regarding current trading prices, CVSGF is priced at $16.50, while EDEMY trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas EDEMY's P/E ratio is 5.12. In terms of profitability, CVSGF's ROE is +0.08%, compared to EDEMY's ROE of +0.32%. Regarding short-term risk, CVSGF is less volatile compared to EDEMY. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check EDEMY's competition here
CVSGF vs MIBE Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, MIBE has a market cap of 80.3M. Regarding current trading prices, CVSGF is priced at $16.50, while MIBE trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas MIBE's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to MIBE's ROE of N/A. Regarding short-term risk, CVSGF and MIBE have similar daily volatility (0.00).Check MIBE's competition here
CVSGF vs WOSSF Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, WOSSF has a market cap of 74.9M. Regarding current trading prices, CVSGF is priced at $16.50, while WOSSF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas WOSSF's P/E ratio is 5.50. In terms of profitability, CVSGF's ROE is +0.08%, compared to WOSSF's ROE of +0.23%. Regarding short-term risk, CVSGF is less volatile compared to WOSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check WOSSF's competition here
CVSGF vs MNNGF Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, MNNGF has a market cap of 58M. Regarding current trading prices, CVSGF is priced at $16.50, while MNNGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas MNNGF's P/E ratio is -7.50. In terms of profitability, CVSGF's ROE is +0.08%, compared to MNNGF's ROE of +0.06%. Regarding short-term risk, CVSGF is less volatile compared to MNNGF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check MNNGF's competition here
CVSGF vs MNLXF Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, MNLXF has a market cap of 40.2M. Regarding current trading prices, CVSGF is priced at $16.50, while MNLXF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas MNLXF's P/E ratio is -4.00. In terms of profitability, CVSGF's ROE is +0.08%, compared to MNLXF's ROE of +2.48%. Regarding short-term risk, CVSGF is less volatile compared to MNLXF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check MNLXF's competition here
CVSGF vs KVIL Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, KVIL has a market cap of 30.5M. Regarding current trading prices, CVSGF is priced at $16.50, while KVIL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas KVIL's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to KVIL's ROE of N/A. Regarding short-term risk, CVSGF and KVIL have similar daily volatility (0.00).Check KVIL's competition here
CVSGF vs GDDFF Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, GDDFF has a market cap of 18.1M. Regarding current trading prices, CVSGF is priced at $16.50, while GDDFF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas GDDFF's P/E ratio is -1.82. In terms of profitability, CVSGF's ROE is +0.08%, compared to GDDFF's ROE of +0.46%. Regarding short-term risk, CVSGF is less volatile compared to GDDFF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check GDDFF's competition here
CVSGF vs AMIH Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, AMIH has a market cap of 195K. Regarding current trading prices, CVSGF is priced at $16.50, while AMIH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas AMIH's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to AMIH's ROE of +0.64%. Regarding short-term risk, CVSGF is less volatile compared to AMIH. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check AMIH's competition here
CVSGF vs GDET Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, GDET has a market cap of 89.9K. Regarding current trading prices, CVSGF is priced at $16.50, while GDET trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas GDET's P/E ratio is -0.10. In terms of profitability, CVSGF's ROE is +0.08%, compared to GDET's ROE of +0.05%. Regarding short-term risk, CVSGF and GDET have similar daily volatility (0.00).Check GDET's competition here
CVSGF vs BZRT Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, BZRT has a market cap of 53.5K. Regarding current trading prices, CVSGF is priced at $16.50, while BZRT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas BZRT's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to BZRT's ROE of +0.00%. Regarding short-term risk, CVSGF and BZRT have similar daily volatility (0.00).Check BZRT's competition here
CVSGF vs AIOM Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, AIOM has a market cap of 34K. Regarding current trading prices, CVSGF is priced at $16.50, while AIOM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas AIOM's P/E ratio is -0.03. In terms of profitability, CVSGF's ROE is +0.08%, compared to AIOM's ROE of -0.10%. Regarding short-term risk, CVSGF is less volatile compared to AIOM. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check AIOM's competition here
CVSGF vs PTTL Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PTTL has a market cap of 7.1K. Regarding current trading prices, CVSGF is priced at $16.50, while PTTL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas PTTL's P/E ratio is -0.01. In terms of profitability, CVSGF's ROE is +0.08%, compared to PTTL's ROE of -1.53%. Regarding short-term risk, CVSGF and PTTL have similar daily volatility (0.00).Check PTTL's competition here
CVSGF vs PNGB Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PNGB has a market cap of 4.9K. Regarding current trading prices, CVSGF is priced at $16.50, while PNGB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas PNGB's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to PNGB's ROE of +15.99%. Regarding short-term risk, CVSGF is less volatile compared to PNGB. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check PNGB's competition here
CVSGF vs CVSC Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CVSC has a market cap of 1.7K. Regarding current trading prices, CVSGF is priced at $16.50, while CVSC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas CVSC's P/E ratio is 0.01. In terms of profitability, CVSGF's ROE is +0.08%, compared to CVSC's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to CVSC. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check CVSC's competition here
CVSGF vs OBDP Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, OBDP has a market cap of 163. Regarding current trading prices, CVSGF is priced at $16.50, while OBDP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas OBDP's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to OBDP's ROE of N/A. Regarding short-term risk, CVSGF and OBDP have similar daily volatility (0.00).Check OBDP's competition here
CVSGF vs PXRB Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PXRB has a market cap of 82. Regarding current trading prices, CVSGF is priced at $16.50, while PXRB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas PXRB's P/E ratio is -0.00. In terms of profitability, CVSGF's ROE is +0.08%, compared to PXRB's ROE of N/A. Regarding short-term risk, CVSGF and PXRB have similar daily volatility (0.00).Check PXRB's competition here
CVSGF vs VLBI Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, VLBI has a market cap of 11. Regarding current trading prices, CVSGF is priced at $16.50, while VLBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas VLBI's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to VLBI's ROE of -0.54%. Regarding short-term risk, CVSGF and VLBI have similar daily volatility (0.00).Check VLBI's competition here
CVSGF vs CPLT Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CPLT has a market cap of 2. Regarding current trading prices, CVSGF is priced at $16.50, while CPLT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas CPLT's P/E ratio is 0.00. In terms of profitability, CVSGF's ROE is +0.08%, compared to CPLT's ROE of N/A. Regarding short-term risk, CVSGF and CPLT have similar daily volatility (0.00).Check CPLT's competition here
CVSGF vs SPRJ Comparison May 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, SPRJ has a market cap of 0. Regarding current trading prices, CVSGF is priced at $16.50, while SPRJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.23, whereas SPRJ's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to SPRJ's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to SPRJ. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check SPRJ's competition here